T4
Showing 9976 - 10000 of >10,000
Immune Damage and Vaccination in COPD Patients
Suspended
- Chronic Obstructive Pulmonary Disease
- Anti-influenza and DTp pertussis vaccinations
-
Créteil, France
- +1 more
Aug 24, 2022
Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)
Therapeutic Adherence and Compliance Trial in New York, Cape Town (Feedback on DBS Concentrations)
Completed
- Therapeutic Adherence and Compliance
- Feedback on DBS Concentrations
-
New York, New York
- +1 more
Dec 27, 2022
Pupillometry for Pain Assessment in ICU Patients With Delirium
Not yet recruiting
- Delirium
- Pain, Postoperative
- automated pupillometry
- questionnaire
-
Brno, Czech Republic, CzechiaSt. Anne's University Hospital in Brno
Apr 12, 2023
Androgenetic Alopecia Trial in Jakarta Pusat (Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil)
Active, not recruiting
- Androgenetic Alopecia
- Platelet-Rich Plasma and Topical 5% Minoxidil
- Topical 5% Minoxidil
-
Jakarta Pusat, Greater Jakarta Area, IndonesiaDr. Cipto Mangunkusumo National General Hospital
Sep 12, 2023
Early Detection of Breast Cancer
Recruiting
- Breast Neoplasms
-
Ann Arbor, MichiganRogel Cancer Center
Sep 18, 2023
Cervical Carcinoma Trial in Chongqing (TC-E202 cells, IL-2, Fludarabine)
Recruiting
- Cervical Carcinoma
- TC-E202 cells
- +3 more
-
Chongqing, Chongqing, ChinaXiaochun Cheng
Oct 20, 2022
Patient Acceptance of Health Care Trial in Shanghai (Methimazole(MMI))
Recruiting
- Patient Acceptance of Health Care
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiaotong University School of Medicine
Sep 4, 2021
COVID-19 Trial in Jakarta, Bandung (Standard of Care + Quinine Sulfate, Standard of Care)
Recruiting
- COVID-19
- Standard of Care + Quinine Sulfate
- Standard of Care
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
Apr 10, 2023
Tobacco Use, Tobacco Smoking, Tobacco Use Cessation Trial in New Brunswick (Persistence Targeted Smoking Cessation in SMI
Completed
- Tobacco Use
- +5 more
- Persistence Targeted Smoking Cessation in SMI (PTSC-S)
- Nicotine patch
-
New Brunswick, New JerseyDivision of Addiction Psychiatry
Aug 19, 2022
Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and
Not yet recruiting
- Epstein-Barr Virus Infection
- +2 more
- Matrix-M1 Adjuvant
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Cognitive Protective Effect of Newer Antidiabetic Drugs
Recruiting
- Type 2 Diabetes
- Dapagliflozin
- +6 more
-
Alexandria, EgyptAlexandria University
Jul 24, 2022
Food Allergy Trial in Netherlands (oral immunotherapy)
Enrolling by invitation
- Food Allergy
- oral immunotherapy
-
Deventer, Overijssel, Netherlands
- +3 more
Feb 11, 2023
Full Automatic Software With Standard Methods of Vessels
Recruiting
- Abdominal Aortic Aneurysm
-
Leipzig, Saxony, GermanyUniversitätsklinikum leipzig
Jun 16, 2023
Frailty Trial in Houston (Vertebral Bone Marrow-Mesenchymal Stem Cells (vBM-MSCs))
Not yet recruiting
- Frailty
- Mesenchymal Stem Cells (MSCs)
-
Houston, TexasMichael E. DeBakey VA Medical Center, Houston, TX
Nov 16, 2022
Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)
Completed
- Malaria
- Midazolam
- +7 more
-
Belfast, Northern Ireland, United KingdomNovartis Investigative Site
Nov 2, 2022
Disease Specific PROM to Assess Abdominal Involvement in CF
Recruiting
- Cystic Fibrosis
- Questionnaire Patient Reported Outcome Measure (PROM)
-
Brandenburg an der Havel, Germany
- +1 more
Sep 26, 2022
Kidney Transplant Rejection, End Stage Renal Disease Trial in Belgium, Netherlands, United Kingdom (TX200-TR101)
Recruiting
- Kidney Transplant Rejection
- End Stage Renal Disease
- TX200-TR101
-
Leuven, Belgium
- +4 more
Sep 30, 2022
Labor Complication, Induced; Birth, Pregnancy Related Trial in Norway (Buscopan 20 MG/ML Injectable Solution, Sodium
Recruiting
- Labor Complication
- +2 more
- Buscopan 20 MG/ML Injectable Solution
- +3 more
-
Lørenskog, Norway
- +4 more
Feb 7, 2023
Healthy Trial (Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU, Active comparator Erythropoietin
Not yet recruiting
- Healthy
- Experimental Erythropoietin subcutaneous injection single dose of 4,000 IU
- Active comparator Erythropoietin Eprex® subcutaneous injection single dose of 4,000 IU
- (no location specified)
Apr 8, 2022
Type 1 Diabetes Trial in Houston (DiaBetter Together, Peer Mentor Delivery)
Enrolling by invitation
- Type 1 Diabetes
- DiaBetter Together
- Peer Mentor Delivery
-
Houston, TexasBaylor College of Medicine
Jun 9, 2022
Clinical Treatments for Patients With Oropharyngeal Carcinoma
Recruiting
- Oropharynx Carcinoma
- Surgery for early-stage OPC
- +4 more
-
Shanghai, Shanghai, ChinaDepartment of Otorhinolaryngology, Eye & ENT Hospital
Apr 18, 2022
Advanced Solid Tumors Trial in Guangzhou (BAT8007 for injection)
Recruiting
- Advanced Solid Tumors
- BAT8007 for injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 26, 2023
Zygomatic-temporal Neuroma Triggering Cluster Headache
Completed
- Cluster Headache
- Craniofacial Pain Syndrome
- Minimal surgical exploration for a neuroma
-
Corona, CaliforniaCorona Doctors Medical Clinics Inc
Nov 25, 2022